{"content":"<li class=\"n-box-item date-title\" data-end=\"1487048399\" data-start=\"1486962000\" data-txt=\"Sunday, December 22, 2019\">Monday, February 13, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3243034\" data-ts=\"1487031246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCI\" target=\"_blank\">CCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243034-crown-castle-borrows-500m-to-mostly-repay-revolving-credit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crown Castle borrows $500M to mostly repay revolving credit</a></h4><ul>   <li>Crown Castle International (<a href='https://seekingalpha.com/symbol/CCI' title='Crown Castle International Corp.'>CCI</a> <font color='green'>+3.1%</font>) has <a href=\"https://seekingalpha.com/pr/16740972-crown-castle-raises-additional-term-loans-extends-maturity-existing-facilities\" target=\"_blank\">borrowed an additional $500M</a> and stretched out the maturity date on its credit.</li>    <li>The company borrowed that sum in Tranche A term loans, used proceeds to repay outstanding revolving borrowings, and has extended the maturity of its senior unsecured credit to Jan. 21, 2022.</li>    <li>That facility has a $2.5B revolving credit facility and now a $2.5B term loan A facility.</li>    <li>After the moves, there's about $2.4B in availability under the revolver.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3243034\" data-linked=\"Crown Castle borrows $500M to mostly repay revolving credit\" data-tweet=\"$CCI - Crown Castle borrows $500M to mostly repay revolving credit https://seekingalpha.com/news/3243034-crown-castle-borrows-500m-to-mostly-repay-revolving-credit?source=tweet\" data-url=\"https://seekingalpha.com/news/3243034-crown-castle-borrows-500m-to-mostly-repay-revolving-credit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243032\" data-ts=\"1487030420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243032-activision-comes-off-highs-hilliard-lyons-goes-bearish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision comes off highs as Hilliard Lyons goes bearish</a></h4><ul>   <li>Activision Blizzard (<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='red'>-3.2%</font>) has given back some gains after Friday's <a href=\"https://seekingalpha.com/news/3242561-activision-blizzard-plus-16_1-percent-new-highs-record-quarter\" target=\"_blank\">sharp move up on record earnings</a>, and Hilliard Lyons is one firm that's giving more play to conservative guidance from the videogame maker.</li>    <li>Hilliard's Jeffrey Thomison has <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9035162/activision-blizzard-just-got-a-new-bear-hilliard-lyons-j\" target=\"_blank\">cut his rating to Underperform</a> ahead of a \"down year,\" reducing expectations for 2017 EPS to $1.92 from $2.20 (vs. consensus $1.94), and for revenue of $6.33B from $7.2B (vs. consensus of $6.4B).</li>    <li>Activision's own full-year guidance is for $6.3B in revenue and $1.85 in EPS. &ldquo;While we feel this guidance is conservative, we also believe it reflects maturation of certain console franchises,&rdquo; Thomison writes.</li>    <li>&ldquo;In sum, we believe 2017 is shaping up to be a down year for ATVI&rsquo;s revenues and earnings, while the stock price is at an all-time high and valuation is near the upper end of a historical range. Given that 2018 prospects seem considerably more attractive, we believe better investment opportunities could surface later this year,&rdquo; he adds.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3243032\" data-linked=\"Activision comes off highs as Hilliard Lyons goes bearish\" data-tweet=\"$ATVI - Activision comes off highs as Hilliard Lyons goes bearish https://seekingalpha.com/news/3243032-activision-comes-off-highs-hilliard-lyons-goes-bearish?source=tweet\" data-url=\"https://seekingalpha.com/news/3243032-activision-comes-off-highs-hilliard-lyons-goes-bearish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243029\" data-ts=\"1487029375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243029-noble-energy-rises-after-stronger-expected-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Energy rises after stronger than expected Q4</a></h4><ul>     <li>Noble Energy (NYSE:<a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a>) <font color='green'>+1.3%</font>&nbsp;AH after reporting much better than expected <a href=\"https://seekingalpha.com/news/3242997-noble-energy-beats-0_36-misses-revenue\" target=\"_blank\">Q4 earnings</a> on 17% higher revenues Y/Y, helped by <a href=\"http://www.reuters.com/article/us-noble-energy-results-idUSKBN15S2HL\" target=\"_blank\">lower expenses and higher oil prices</a>.</li>     <li>NBL says Q4 total sales volumes fell 2.8% Y/Y to 410K boe/day but at the top end of its guidance range, while the average realized price for crude oil jumped 22% and its realized price for natural gas rose 20%; total operating expenses fell 46% to $1.37B after FY 2016 spending dropped 15% to $4.8B from $5.7B in 2015.</li><li>NBL expects FY 2017 sales volumes to average 415K-425K boe/day, up ~9% Y/Y, including sales from newly acquired Clayton Williams&nbsp;Energy, with the expected closing of the deal in Q2.</li><li>NBL also forecasts 2017 organic capex of $2.3B-$2.6B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3243029\" data-linked=\"Noble Energy rises after stronger than expected Q4\" data-tweet=\"$NBL - Noble Energy rises after stronger than expected Q4 https://seekingalpha.com/news/3243029-noble-energy-rises-after-stronger-expected-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3243029-noble-energy-rises-after-stronger-expected-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243028\" data-ts=\"1487028870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243028-analysts-verizons-unlimited-play-bad-omen-for-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts: Verizon&#39;s unlimited play a bad omen for sector</a></h4><ul>   <li>All four major U.S. wireless carriers dropped today in the wake of Verizon's return to <a href=\"https://seekingalpha.com/news/3242843-big-four-wireless-lower-verizon-returns-unlimited-well\" target=\"_blank\">offering unlimited data plans</a>, and analysts tend to agree that the move will <a href=\"http://blogs.barrons.com/techtraderdaily/2017/02/13/verizon-goes-unlimited-this-is-bad-for-everyone-says-street\" target=\"_blank\">mess up economics for all of them</a>.</li>    <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) shares <font color='red'>fell 0.9%</font> today, while AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) <font color='red'>dropped 1.8%</font>, Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <font color='red'>slipped 1.3%</font> and T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) -- a net taker of customers from Verizon that emphasizes its unlimited pricing -- <font color='red'>fell a full 2.4%</font>.</li>    <li>Reactions to Verizon's plan note its expense (more so than T-Mobile or Sprint) and aggressive speed throttling after users pass a data cap (common among carriers' \"unlimited\" plans).</li>    <li>Evercore has a Hold rating on Verizon, and notes that throttling users at 22 GB in a month and at 10 GB of hotspot use is an \"incremental negative for all carriers.\" The move will be accretive to ARPU at first, says Vijay Jayant, but dilutive in the long term as customers' bills stay put even as usage rises.</li>    <li>Instinet's Jeffrey Kvaal reiterated a Neutral rating and says the move may be a \"nail in the coffin\" for revenue growth: \"For T-Mobile and Sprint, the potential for reduced top-line growth is less of a concern as investors focus on Adjusted EBITDA and FCF. AT&amp;T and Verizon, however, must pursue growth outside the industry.\" And while AT&amp;T is counting on DirecTV and Time Warner, Verizon's flat guidance suggests a need for inorganic options.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3243028\" data-linked=\"Analysts: Verizon&#39;s unlimited play a bad omen for sector\" data-tweet=\"$VZ $VZ $T - Analysts: Verizon&#39;s unlimited play a bad omen for sector https://seekingalpha.com/news/3243028-analysts-verizons-unlimited-play-bad-omen-for-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3243028-analysts-verizons-unlimited-play-bad-omen-for-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243033\" data-ts=\"1487027460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLDP\" target=\"_blank\">BLDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243033-ballard-power-to-deploy-20-zero-emission-fuel-cell-electric-buses-in-california\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ballard Power to deploy 20 zero-emission fuel cell electric buses in California</a></h4><ul><li>Ballard Power (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a>) <font color='green'>+4.5%</font> AH on news it has joined a consortium with New Flyer Industries to <a href=\"https://seekingalpha.com/pr/16741051-ballard-consortium-new-flyer-deploy-20-zero-emission-fuel-cell-electric-buses-ca\" target=\"_blank\">deploy 20 zero-emission fuel cell electric buses</a> in California.</li><li>BLDP will provide 20 of its FCveloCity-HD 85 KW fuel cell  engines to New Flyer, North America's largest transit bus and motor coach  manufacturer and parts distributor, and the engines  will power New Flyer 40-foot Xcelsior XHE40 fuel cell buses, which are  planned to be delivered by year-end 2018.</li><li>The FCEBCC project is funded and sponsored by the California Air  Resources Board, the Bay Area Air Quality Management District,  and the South  Coast Air Quality Management District.</li></ul><div class=\"tiny-share-widget\" data-id=\"3243033\" data-linked=\"Ballard Power to deploy 20 zero-emission fuel cell electric buses in California\" data-tweet=\"$BLDP - Ballard Power to deploy 20 zero-emission fuel cell electric buses in California https://seekingalpha.com/news/3243033-ballard-power-to-deploy-20-zero-emission-fuel-cell-electric-buses-in-california?source=tweet\" data-url=\"https://seekingalpha.com/news/3243033-ballard-power-to-deploy-20-zero-emission-fuel-cell-electric-buses-in-california\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243020\" data-ts=\"1487026577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243020-ringcentralminus-9-despite-q4-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral -9% despite Q4 earnings beat</a></h4><ul>   <li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) is <font color='red'>off 9%</font> now after hours following <a href=\"https://seekingalpha.com/news/3242972-ringcentral-beats-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a> where it beat expectations on top and bottom lines, but provided earnings-call profit guidance on the light side for the upcoming quarter.</li>    <li>Overall revenue was up 25.2% and software subscriptions (the bulk of revenue) rose 28% to $98M.</li>    <li>Annualized exit recurring software subscriptions grew 31% to $414.4M; of that, ARR for RingCentral Office grew 38%, to $341.5M. Gross margin on software subscriptions rose to 81.2% on a non-GAAP basis.</li>    <li>The company guided to software revenue of $102M-$103M for Q1 (28-29% growth) and total revenue of $109.5M-$111.5M, above consensus for $106.7M. It's expecting EPS of $0.01-$0.03, vs. consensus for $0.03.</li>    <li>For the full year, it's forecasting software revenue of $447M-$454M (26-28% growth) and total revenue of $484M-$492M, above consensus for $468M. It sees EPS of $0.13-$0.17 vs. consensus for $0.15.</li>    <li><a href=\"https://seekingalpha.com/article/4045515-ringcentral-inc-2016-q4-results-earnings-call-slides#\" target=\"_blank\">Earnings call slides</a></li>    <li><a href=\"https://seekingalpha.com/pr/16740927-ringcentral-announces-fourth-quarter-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3243020\" data-linked=\"RingCentral -9% despite Q4 earnings beat\" data-tweet=\"$RNG - RingCentral -9% despite Q4 earnings beat https://seekingalpha.com/news/3243020-ringcentralminus-9-despite-q4-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3243020-ringcentralminus-9-despite-q4-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243017\" data-ts=\"1487025730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMKR\" target=\"_blank\">AMKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243017-amkor-technologyminus-9_5-q1-2017-revenue-outlook-negative-seasonal-smartphone-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amkor Technology -9.5%; Q1 2017 revenue outlook negative, seasonal smartphone market slowdown noted</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3242968-amkor-technology-eps-0_42\" target=\"_blank\">Q4 2016 results</a></strong> &ndash; revenue $1.02B (+52.1% Y/Y,&nbsp;<font color='red'>$20M below estimates</font>), EPS $0.42 (<a href=\"https://finance.yahoo.com/quote/AMKR/analysts?p=AMKR\" target=\"_blank\">consensus $0.27</a>), gross margin 22.2% (vs. 19.7% Q/Q, 15.3% Y/Y), net income $100M (vs. $60M Q/Q, -$11M Y/Y), EBITDA $280M (vs. $248M Q/Q, $130M Y/Y), net cash provided by operating activities $238M (vs. $219M Q/Q, $154M Y/Y), free cash flow $117M (vs. $106M Q/Q, -$29M Y/Y)</li><li><strong>Q1 2017 projections</strong> &ndash; revenue $860M-$940M (-8% to -16% Q/Q; <a href=\"https://finance.yahoo.com/quote/AMKR/analysts?p=AMKR\" target=\"_blank\">consensus $964.48M</a>), EPS -$0.11 to $0.05 (consensus $0.11), gross margin 13%-17%</li><li><strong>FY 2017 projections</strong> &ndash; capital expenditures approximately $500M</li><li>Amkor Technology president and CEO Steve Kelley: \"The consolidation of J-Devices and the success of our automotive,&nbsp;Greater China&nbsp;and advanced SiP initiatives fueled the growth in revenue, which in turn drove significantly improved profitability and cash flow.\"</li><li>Although citing smartphone market slowdown, demand in other markets is claimed healthy.</li><li><strong>After hours</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/AMKR' title='Amkor Technology, Inc.'>AMKR</a>) $9.45</li><li><a href=\"https://seekingalpha.com/article/4045513-amkor-technology-inc-2016-q4-results-earnings-call-slides\" target=\"_blank\">Presentation slides</a></li><li><a href=\"http://ir.amkor.com/phoenix.zhtml?p=irol-eventDetails&amp;c=115640&amp;eventID=5247191\" target=\"_blank\">Conference call</a></li><li><a href=\"https://seekingalpha.com/pr/16740932-amkor-technology-reports-financial-results-fourth-quarter-full-year-2016\" target=\"_blank\">Press release</a></li><li><a href=\"https://seekingalpha.com/filing/3403372\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3243017\" data-linked=\"Amkor Technology -9.5%; Q1 2017 revenue outlook negative, seasonal smartphone market slowdown noted\" data-tweet=\"$AMKR - Amkor Technology -9.5%; Q1 2017 revenue outlook negative, seasonal smartphone market slowdown noted https://seekingalpha.com/news/3243017-amkor-technologyminus-9_5-q1-2017-revenue-outlook-negative-seasonal-smartphone-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3243017-amkor-technologyminus-9_5-q1-2017-revenue-outlook-negative-seasonal-smartphone-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243015\" data-ts=\"1487025385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243015-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+7.0%</font>. <a href='https://seekingalpha.com/symbol/GUID' title='Guidance Software, Inc.'>GUID</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/NVTA' title='Invitae'>NVTA</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications'>QTNA</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/CSOD' title='Cornerstone OnDemand, Inc.'>CSOD</a> <font color='green'>+3.3%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='red'>-15.8%</font>. <a href='https://seekingalpha.com/symbol/AMKR' title='Amkor Technology, Inc.'>AMKR</a> <font color='red'>-9.0%</font>. <a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a> <font color='red'>-6.5%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='red'>-5.1%</font>. <a href='https://seekingalpha.com/symbol/GLNG' title='Golar LNG Limited'>GLNG</a> <font color='red'>-5.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3243015\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$BLDP $GUID $NVTA - After Hours Gainers / Losers https://seekingalpha.com/news/3243015-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3243015-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243009\" data-ts=\"1487024267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243009-transenterixplus-5-first-clinical-use-of-senhance-overseas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transenterix +5%, first clinical use of Senhance overseas</a></h4><ul><li>The company <a href=\"https://seekingalpha.com/pr/16740918-transenterix-announces-first-clinical-use-senhance-robotic-surgical-system-france\" target=\"_blank\">has begun clinical use</a> of the Senhance Robotic Surgical System in France.</li><li>The first case - a hysterectomy for endometrial cancer with pelvic lymphadenectomy - was performed on Feb. 7. Surgery was successful and the patient discharged less than 24 hours after the procedure.</li><li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>&nbsp;<font color='green'>+5.2%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3243009\" data-linked=\"Transenterix +5%, first clinical use of Senhance overseas\" data-tweet=\"$TRXC - Transenterix +5%, first clinical use of Senhance overseas https://seekingalpha.com/news/3243009-transenterixplus-5-first-clinical-use-of-senhance-overseas?source=tweet\" data-url=\"https://seekingalpha.com/news/3243009-transenterixplus-5-first-clinical-use-of-senhance-overseas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243006\" data-ts=\"1487022623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243006-lilly-and-incytes-baricitinib-okd-in-europe-incyte-earns-65m-milestone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilly and Incyte&#39;s baricitinib OK&#39;d in Europe; Incyte earns $65M milestone</a></h4><ul><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;after hours on light volume in response to the news that the European Commission has <a href=\"https://seekingalpha.com/pr/16740977-european-commission-approves-daily-olumiant-tablets-treatment-adults-moderate-severe-active\" target=\"_blank\">approved </a>Olumiant (baricitinib) for the treatment of moderately-to-severely active rheumatoid arthritis &#40;RA&#41; in adult patients who have failed to respond adequately to or are intolerant of disease-modifying antirheumatic drugs (DMARDs).</li><li>Baricitinib is the first JAK inhibitor to be approved in the EU to treat RA. It is being developed with Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) under a 2009 exclusive global license and collaboration agreement.</li><li>The approval triggers a $65M milestone payment from Lilly to Incyte.</li></ul><div class=\"tiny-share-widget\" data-id=\"3243006\" data-linked=\"Lilly and Incyte&#39;s baricitinib OK&#39;d in Europe; Incyte earns $65M milestone\" data-tweet=\"$INCY $INCY $LLY - Lilly and Incyte&#39;s baricitinib OK&#39;d in Europe; Incyte earns $65M milestone https://seekingalpha.com/news/3243006-lilly-and-incytes-baricitinib-okd-in-europe-incyte-earns-65m-milestone?source=tweet\" data-url=\"https://seekingalpha.com/news/3243006-lilly-and-incytes-baricitinib-okd-in-europe-incyte-earns-65m-milestone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243004\" data-ts=\"1487022321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDTI\" target=\"_blank\">IDTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243004-gigpeakplus-12_18-integrated-device-technology-acquiring-for-3_08-per-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GigPeak +12.18%; Integrated Device Technology acquiring for $3.08 per share</a></h4><ul><li>Accompanying release of GigPeak's <a href=\"https://seekingalpha.com/pr/16740976-gigpeak-reports-record-financial-performance-fourth-quarter-fiscal-year-2016-enters\" target=\"_blank\">Q4 2016 report</a>, disclosure is made Integrated Device Technology plans to acquire GigPeak in a $250M all-cash deal, unanimously approved by the boards of both companies and <a href=\"https://seekingalpha.com/pr/16740998-idt-acquire-gigpeak-3_08-per-share\" target=\"_blank\">expected for accretion</a> to Integrated Device Technology earnings within the first full quarter subsequent transaction close (expected calendar Q2 2017).</li><li>Integrated Device Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IDTI' title='Integrated Device Technology, Inc.'>IDTI</a>) $24.50,&nbsp;<font color='red'>-0.93%</font>&nbsp;after hours, GigPeak (NYSEMKT:<a href='https://seekingalpha.com/symbol/GIG' title='GigPeak, Inc.'>GIG</a>) $3.04.</li></ul><div class=\"tiny-share-widget\" data-id=\"3243004\" data-linked=\"GigPeak +12.18%; Integrated Device Technology acquiring for $3.08 per share\" data-tweet=\"$IDTI $IDTI $GIG - GigPeak +12.18%; Integrated Device Technology acquiring for $3.08 per share https://seekingalpha.com/news/3243004-gigpeakplus-12_18-integrated-device-technology-acquiring-for-3_08-per-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3243004-gigpeakplus-12_18-integrated-device-technology-acquiring-for-3_08-per-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243003\" data-ts=\"1487022184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFLT\" target=\"_blank\">PFLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243003-pennantpark-floating-rateminus-2_7-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PennantPark Floating Rate -2.7% on capital raise</a></h4><ul><li>The company is selling 5M shares in a secondary offering, with underwriters offered a 750K share greenshoe option.</li><li>PennantPark (NASDAQ:<a href='https://seekingalpha.com/symbol/PFLT' title='PennantPark Floating Rate Capital'>PFLT</a>) last week reported end-of-year NAV of $14.11 and closed today at $14.01.</li><li>Shares are&nbsp;<font color='red'>down 2.7%</font>&nbsp;after hours to $13.63.</li></ul><div class=\"tiny-share-widget\" data-id=\"3243003\" data-linked=\"PennantPark Floating Rate -2.7% on capital raise\" data-tweet=\"$PFLT - PennantPark Floating Rate -2.7% on capital raise https://seekingalpha.com/news/3243003-pennantpark-floating-rateminus-2_7-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3243003-pennantpark-floating-rateminus-2_7-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243001\" data-ts=\"1487021975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMF\" target=\"_blank\">OMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243001-onemainminus-3_7-earnings-miss-delinquencies-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneMain -3.7%; earnings miss, delinquencies rise</a></h4><ul><li>Consumer and Insurance segment adjusted pretax earnings of $175M up from $143M a year ago. EPS of $0.80 vs. $0.66. Expectations were for $0.81.</li><li>Net finance receivables of $13.5B up from $13B; net charge-off ratio of 7.5%.</li><li>The 30-89 day delinquency ratio of 2.3% at year end slipped from 2.6% three months earlier, and was up from 2.2% a year ago.</li><li>The 60+ delinquency ratio of 3.6% at year end was up from 3.3% three months earlier and from 3% a year ago.</li><li><a href=\"https://www.onemainfinancial.com\" target=\"_blank\">Conference call</a> tomorrow at 8 ET</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242996-onemain-holdings-eps-0_20\" target=\"_blank\">OneMain Holdings EPS of $0.20</a> (Feb. 13)</li><li><a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a>&nbsp;<font color='red'>-3.7%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3243001\" data-linked=\"OneMain -3.7%; earnings miss, delinquencies rise\" data-tweet=\"$OMF - OneMain -3.7%; earnings miss, delinquencies rise https://seekingalpha.com/news/3243001-onemainminus-3_7-earnings-miss-delinquencies-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3243001-onemainminus-3_7-earnings-miss-delinquencies-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242991\" data-ts=\"1487021043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSOD\" target=\"_blank\">CSOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242991-cornerstone-ondemandplus-4_87-q4-2016-positive-revenue-outlook-below-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cornerstone OnDemand +4.87%; Q4 2016 positive, revenue outlook below estimates</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3242958-cornerstone-ondemand-beats-0_04-beats-revenue\" target=\"_blank\">Q4 2016 results</a></strong> &ndash; revenue $109.03M (+13.6% Y/Y,&nbsp;<font color='green'>$0.52M above estimates</font>), EPS $0.00 (<font color='green'>$0.04 above estimates</font>), billings $156.3M (+10.1% Y/Y), operating loss $14.5M (vs. $14.8M operating loss Y/Y), operating income $1.6M (vs. $0.2M Y/Y), net loss $18.6M (vs. $18.8M net loss Y/Y), free cash flow $27.5M (vs. $49.2M Y/Y)</li><li><strong>Q1 2017 projections</strong> &ndash; revenue $109M-$111M (<a href=\"https://finance.yahoo.com/quote/CSOD/analysts?p=CSOD\" target=\"_blank\">consensus $113.87M</a>)</li><li><strong>FY 2017 projections</strong> &ndash; revenue $475M-$485M (consensus $488.63M), operating margin 5%-6%, net income margin 4%-5%, free cash flow 6%-7% of revenue</li><li>Cornerstone OnDemand president and CEO Adam Miller: \"We believe the tremendous market opportunity in learning and human capital management, combined with our position as the long-standing talent management leader and our proven ability to innovate, will continue to fuel Cornerstone&rsquo;s long-term growth and margin expansion.\"</li><li><strong>After hours</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/CSOD' title='Cornerstone OnDemand, Inc.'>CSOD</a>) $41.97</li><li><a href=\"http://s2.q4cdn.com/578454011/files/doc_financials/quarterly_reports/2016/q4/Q4-2016-Supplemental-Data.pdf\" target=\"_blank\">Supplemental data</a></li><li><a href=\"http://edge.media-server.com/m/p/9c27dm2i\" target=\"_blank\">Conference call</a></li><li><a href=\"https://seekingalpha.com/pr/16740904-cornerstone-ondemand-announces-fourth-quarter-fiscal-year-2016-financial-results\" target=\"_blank\">Press release</a></li><li><a href=\"https://seekingalpha.com/filing/3403282\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242991\" data-linked=\"Cornerstone OnDemand +4.87%; Q4 2016 positive, revenue outlook below estimates\" data-tweet=\"$CSOD - Cornerstone OnDemand +4.87%; Q4 2016 positive, revenue outlook below estimates https://seekingalpha.com/news/3242991-cornerstone-ondemandplus-4_87-q4-2016-positive-revenue-outlook-below-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3242991-cornerstone-ondemandplus-4_87-q4-2016-positive-revenue-outlook-below-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242990\" data-ts=\"1487021036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIG\" target=\"_blank\">GIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242990-gigpeak-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GigPeak EPS in-line, beats on revenue</a></h4><ul><li>GigPeak (NYSEMKT:<a href='https://seekingalpha.com/symbol/GIG' title='GigPeak, Inc.'>GIG</a>): Q4 EPS of $0.05 in-line.</li><li>Revenue of $16.22M (+46.5% Y/Y) <font color='green'>beats by $0.04M</font>.</li><li>Shares <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/pr/16740976-gigpeak-reports-record-financial-performance-fourth-quarter-fiscal-year-2016-enters'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242990\" data-linked=\"GigPeak EPS in-line, beats on revenue\" data-tweet=\"$GIG - GigPeak EPS in-line, beats on revenue https://seekingalpha.com/news/3242990-gigpeak-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3242990-gigpeak-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242984\" data-ts=\"1487020632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242984-gevominus-22-after-announcing-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo -22% after announcing public offering</a></h4><ul>     <li>Gevo (NASDAQ:<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>) <font color='red'>-22.3%</font>&nbsp;AH after announcing a proposed <a href=\"https://seekingalpha.com/pr/16740937-gevo-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">public offering</a> of common stock and warrants of an unspecified size.</li>     <li>Gevo says it plans to use 15% of the proceeds from the offering to pay down part of its outstanding 10% convertible senior secured notes due 2017, with the rest to be used to fund working capital and for other general corporate purposes.</li>     <li>Gevo also says it is <a href=\"https://seekingalpha.com/pr/16740891-senior-secured-lender-agrees-extend-maturity-gevo-s-2017-notes-march-15-2017-june-23-2017\" target=\"_blank\">extending the maturity date</a> of the 2017 notes to June 23 from March 15.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242984\" data-linked=\"Gevo -22% after announcing public offering\" data-tweet=\"$GEVO - Gevo -22% after announcing public offering https://seekingalpha.com/news/3242984-gevominus-22-after-announcing-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3242984-gevominus-22-after-announcing-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242983\" data-ts=\"1487020562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVTA\" target=\"_blank\">NVTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242983-invitae-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invitae beats by $0.04, beats on revenue</a></h4><ul><li>Invitae (NYSE:<a href='https://seekingalpha.com/symbol/NVTA' title='Invitae'>NVTA</a>): Q4 EPS of -$0.69 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $9.2M (+191.1% Y/Y) <font color='green'>beats by $0.38M</font>.</li><li>Shares <font color='green'>+2%</font>.</li><li><a href='https://seekingalpha.com/pr/16740906-invitae-reports-revenue-9_2-million-fourth-quarter-2016-projects-strong-volume-revenue-growth'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242983\" data-linked=\"Invitae beats by $0.04, beats on revenue\" data-tweet=\"$NVTA - Invitae beats by $0.04, beats on revenue https://seekingalpha.com/news/3242983-invitae-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3242983-invitae-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242981\" data-ts=\"1487020456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKD\" target=\"_blank\">BKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242981-brookdale-senior-slumps-5-after-gloomy-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookdale Senior slumps more than 5% after gloomy outlook</a></h4><ul><li>CEO Andy Smith: \"We are operating in a difficult environment with intense supply pressure and a competitive labor market ...&nbsp;supply and labor pressures will continue for the majority of 2017.\"</li><li>The company reported adjusted EBITDA for Q4 of $184.2M, up 3.5% Y/Y. Excluding&nbsp;integration, transaction, transaction-related and strategic project costs, adjusted EBITDA in Q4 was $194.2M.</li><li>Adjusted free cash flow of $33.2M was up $65.9M from a year ago.</li><li>Adjusted CFFO of $81.5M down 7.1% Y/Y.</li><li>Full-year outlook: Adjusted EBITDA excl. costs of $670M-$710M vs. $825M in 2016; adjusted free cash flow of $140M-$170M.</li><li><a href=\"http://www.brookdale.com\" target=\"_blank\">Conference call</a> tomorrow at 10 ET</li><li><a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a>&nbsp;<font color='red'>-5.65%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3242981\" data-linked=\"Brookdale Senior slumps more than 5% after gloomy outlook\" data-tweet=\"$BKD - Brookdale Senior slumps more than 5% after gloomy outlook https://seekingalpha.com/news/3242981-brookdale-senior-slumps-5-after-gloomy-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3242981-brookdale-senior-slumps-5-after-gloomy-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242971\" data-ts=\"1487020175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KOOL\" target=\"_blank\">KOOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242971-cesca-therapeutics-reports-fq2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cesca Therapeutics reports FQ2 results</a></h4><ul><li>Cesca Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc'>KOOL</a>): FQ2 Net loss of $3.4M.</li><li>Revenue of $4M (+21.2% Y/Y)</li><li>Shares <font color='green'>+6.9%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16740916-cesca-therapeutics-reports-second-quarter-fiscal-2017-financial-results-provides-business\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242971\" data-linked=\"Cesca Therapeutics reports FQ2 results\" data-tweet=\"$KOOL $THMO - Cesca Therapeutics reports FQ2 results https://seekingalpha.com/news/3242971-cesca-therapeutics-reports-fq2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3242971-cesca-therapeutics-reports-fq2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242950\" data-ts=\"1487019194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INOV\" target=\"_blank\">INOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242950-inovalon-fails-to-push-through-two-downgrades-shares-off-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovalon fails to push through two downgrades; shares off 9%</a></h4><ul><li>Inovalon Holdings (<a href='https://seekingalpha.com/symbol/INOV' title='Inovalon'>INOV</a> <font color='red'>-8.8%</font>) appears that it will end the session in the red after Bank of America downgraded it to Underperform with a $10 (11% downside risk)&nbsp;price target and Wells Fargo downgraded it to Market Perform.</li><li>BofA analyst Steven Vallquette cites the drop in health plans from exchanges as a key negative plus lower enrollment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242950\" data-linked=\"Inovalon fails to push through two downgrades; shares off 9%\" data-tweet=\"$INOV - Inovalon fails to push through two downgrades; shares off 9% https://seekingalpha.com/news/3242950-inovalon-fails-to-push-through-two-downgrades-shares-off-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3242950-inovalon-fails-to-push-through-two-downgrades-shares-off-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242951\" data-ts=\"1487019063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KS\" target=\"_blank\">KS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242951-containerboard-price-increase-on-radar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Containerboard price increase on the radar</a></h4><ul><li>BMO Capital says KapStone Paper and Packaging Corp (<a href='https://seekingalpha.com/symbol/KS' title='KapStone Paper and Packaging Corporation'>KS</a> <font color='green'>+1.4%</font>) boosted containerboard prices by $50 per ton for the spring season.</li><li>KapStone was up over 2% earlier, but has peeled back. International Paper (<a href='https://seekingalpha.com/symbol/IP' title='International Paper Co.'>IP</a> <font color='red'>-0.3%</font>) and Packaging Corp of America (<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation Of America'>PKG</a> <font color='green'>+0.9%</font>) have also hit reverse after a mid-day spike.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242951\" data-linked=\"Containerboard price increase on the radar\" data-tweet=\"$KS $KS $IP - Containerboard price increase on the radar https://seekingalpha.com/news/3242951-containerboard-price-increase-on-radar?source=tweet\" data-url=\"https://seekingalpha.com/news/3242951-containerboard-price-increase-on-radar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3243026\" data-ts=\"1487017931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CECE\" target=\"_blank\">CECE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3243026-ceco-environmentalminus-9-spruce-point-predicts-covenant-breach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CECO Environmental -9% as Spruce Point predicts covenant breach</a></h4><ul>     <li>CECO&nbsp;Environmental (<a href='https://seekingalpha.com/symbol/CECE' title='CECO Environmental Corp.'>CECE</a> <font color='red'>-8.9%</font>) plunges nearly 10% following a <a href=\"http://www.sprucepointcap.com/ceco-environmental-corp/\" target=\"_blank\">negative report</a> from Spruce Point Capital, which calls the stock a Strong Sell and discloses a short position.</li>     <li>Spruce Point says it believes CECO is at \"high risk\" of a covenant breach in 2017, citing its forensic financial analysis, insider behavior and anticipated changes in the regulatory environment driving its business.</li><li>CECO has said its current net debt to EBITDA ratio has dropped to 1.6x from 3.6x, but Spruce Point finds problems with the company's &ldquo;leverage ratio&rdquo;  covenant in its credit agreement, which looks at gross leverage and includes much more debt obligations beyond just  its term loan.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3243026\" data-linked=\"CECO Environmental -9% as Spruce Point predicts covenant breach\" data-tweet=\"$CECE - CECO Environmental -9% as Spruce Point predicts covenant breach https://seekingalpha.com/news/3243026-ceco-environmentalminus-9-spruce-point-predicts-covenant-breach?source=tweet\" data-url=\"https://seekingalpha.com/news/3243026-ceco-environmentalminus-9-spruce-point-predicts-covenant-breach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242948\" data-ts=\"1487017616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242948-banks-lead-again-hatch-calls-dodd-frank-worse-obamacare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Banks lead again; Hatch calls Dodd-Frank &#39;worse than Obamacare&#39;</a></h4><ul><li>Dodd-Frank is \"an overreach in every way,\" Senate Finance Committee Chairman Orrin Hatch tells Bloomberg.</li><li>The post-crisis law treats all banks \"like they're a bunch of crooks,\" and this can't continue.</li><li>The Financial Sector SPDR (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+1%</font>), the SPDR KBW Bank ETF (<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> <font color='green'>+1%</font>), the SPDR KBW Regional Banking ETF (<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> <font color='green'>+0.9%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Guggenheim S&P Equal Weight Financial ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares UltraPro Financials ETF'>FINU</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a>, <a href='https://seekingalpha.com/symbol/XLFS' title='Financial Services Select Sector SPDR ETF'>XLFS</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/JHMF' title='John Hancock Multifactor Financials ETF'>JHMF</a>, <a href='https://seekingalpha.com/symbol/FAZZ' title='Direxion Daily Financial Bear 1x Shares ETF'>FAZZ</a>, <a href='https://seekingalpha.com/symbol/FNCF' title='iShares Edge MSCI Multifactor Financials ETF'>FNCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242948\" data-linked=\"Banks lead again; Hatch calls Dodd-Frank &#39;worse than Obamacare&#39;\" data-tweet=\"$XLF $KBE $KRE - Banks lead again; Hatch calls Dodd-Frank &#39;worse than Obamacare&#39; https://seekingalpha.com/news/3242948-banks-lead-again-hatch-calls-dodd-frank-worse-obamacare?source=tweet\" data-url=\"https://seekingalpha.com/news/3242948-banks-lead-again-hatch-calls-dodd-frank-worse-obamacare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242946\" data-ts=\"1487017447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QSR\" target=\"_blank\">QSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242946-popeyes-flys-higher-restaurant-brands-on-hunt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Popeyes flys higher with Restaurant Brands on the hunt</a></h4><ul><li>Restaurant Brands International (<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a> <font color='green'>+4.5%</font>) has approached Popeyes Louisiana Kitchen (PLKI <font color='green'>+12.4%</font>) about a <a href=\"http://www.reuters.com/article/us-popeyes-m-a-rstrnt-brnd-exclusive-idUSKBN15S2C9\" target=\"_blank\">takeover offer</a>, according to Reuters.</li><li>Sources indicate that talks are still ongoing.</li><li>Popeyes shot to an all-time high of $74.90 off the buzz.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242946\" data-linked=\"Popeyes flys higher with Restaurant Brands on the hunt\" data-tweet=\"$QSR - Popeyes flys higher with Restaurant Brands on the hunt https://seekingalpha.com/news/3242946-popeyes-flys-higher-restaurant-brands-on-hunt?source=tweet\" data-url=\"https://seekingalpha.com/news/3242946-popeyes-flys-higher-restaurant-brands-on-hunt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242944\" data-ts=\"1487017100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QSR\" target=\"_blank\">QSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242944-popeyes-louisiana-kitchenplus-11-on-buyout-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Popeyes Louisiana Kitchen +11% on buyout report</a></h4><ul><li>Reuters is reporting interest from Restaurant Brands (<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a> <font color='green'>+4%</font>).</li><li>PLKI&nbsp;<font color='green'>+10.9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3242944\" data-linked=\"Popeyes Louisiana Kitchen +11% on buyout report\" data-tweet=\"$QSR - Popeyes Louisiana Kitchen +11% on buyout report https://seekingalpha.com/news/3242944-popeyes-louisiana-kitchenplus-11-on-buyout-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3242944-popeyes-louisiana-kitchenplus-11-on-buyout-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242938\" data-ts=\"1487016005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242938-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INOV' title='Inovalon'>INOV</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PERI' title='Perion Network Ltd.'>PERI</a> <font color='red'>-7%</font>. NQ <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242938\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$AEHR $CTRL $ACIA - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3242938-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3242938-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242936\" data-ts=\"1487015761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DO\" target=\"_blank\">DO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242936-diamond-offshoreplus-2-after-issuing-revised-q4-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diamond Offshore +2% after issuing revised Q4 earnings</a></h4><ul>     <li>Diamond Offshore (<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='green'>+1.9%</font>) is higher after <a href=\"https://seekingalpha.com/pr/16739881-diamond-offshore-announces-tax-expense-adjustment-fourth-quarter-full-year-2016-earnings\" target=\"_blank\">revising</a> previously announced <a href=\"https://seekingalpha.com/news/3240660-diamond-offshore-drilling-beats-0_40-beats-revenue\" target=\"_blank\">Q4 earnings</a>, saying its liability for uncertain tax positions  in certain foreign jurisdictions did not appropriately  reflect changes in foreign exchange rates.</li><li>DO's Q4 net income rose by  $43M, or ~$0.32 per diluted share, and net loss for FY 2016 declined by $43M, or $0.31 per  diluted share.</li>     <li>DO last week reported Q4 EPS of $0.53, including a $0.26/share benefit attributable to a contract dispute  settlement with a client in the North Sea.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242936\" data-linked=\"Diamond Offshore +2% after issuing revised Q4 earnings\" data-tweet=\"$DO - Diamond Offshore +2% after issuing revised Q4 earnings https://seekingalpha.com/news/3242936-diamond-offshoreplus-2-after-issuing-revised-q4-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3242936-diamond-offshoreplus-2-after-issuing-revised-q4-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242935\" data-ts=\"1487015012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRR\" target=\"_blank\">RRR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242935-red-rock-resorts-pulls-share-offering-catches-buy-rating-from-aegis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Rock Resorts pulls share offering, catches buy rating from Aegis</a></h4><ul>     <li>Red Rock Resorts (<a href='https://seekingalpha.com/symbol/RRR' title='Red Rock Resorts'>RRR</a> <font color='green'>+0.9%</font>) files to withdraw a planned offering of shares.</li>     <li>Earlier today, Aegis Capital initiated coverage on Red Rock with a Buy rating and $27 price target.</li>     <li>\"Given shares trade ~14% below our CY18 target price, we are buyers at current levels but would also look to be more aggressive on any potential share price dip from potential CY17 consensus adjustments stemming from short-term construction disruption to the benefit the portfolio longer-term,\" writes analyst David Bain.</li>     <li><a href=\"https://seekingalpha.com/filing/3402623\" target=\"_blank\">SEC Form RW</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3242935\" data-linked=\"Red Rock Resorts pulls share offering, catches buy rating from Aegis\" data-tweet=\"$RRR - Red Rock Resorts pulls share offering, catches buy rating from Aegis https://seekingalpha.com/news/3242935-red-rock-resorts-pulls-share-offering-catches-buy-rating-from-aegis?source=tweet\" data-url=\"https://seekingalpha.com/news/3242935-red-rock-resorts-pulls-share-offering-catches-buy-rating-from-aegis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242934\" data-ts=\"1487014285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HFC\" target=\"_blank\">HFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242934-hollyfrontier-slapped-sell-rating-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HollyFrontier slapped with Sell rating at Goldman</a></h4><ul><li>HollyFrontier (<a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corp.'>HFC</a> <font color='red'>-1.5%</font>) is initiated with a <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/02/13/goldman-sachs-hollyfrontier-has-farther-to-fall/\" target=\"_blank\">Sell rating</a> and a $26 price target at Goldman Sachs, which cites worries about earnings power in the Rocky Mountain refining segment, curtailed buyback potential due to a lack of free cash flow generation, and relatively low refining margins in H1 of this year.</li><li>Goldman sees substantial downside to HFC's earnings consensus, and now expects EPS of $1.16, $2.04 and $2.42 during 2017-19, down from its previous outlook for a respective $1.65, $2.31 and $3.49, and believes Wall Street is currently modeling overly optimistic expectations for HFC's realized refining margins in light of elevated product inventories and turnarounds.</li><li>Goldman says it prefers Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='red'>-0.8%</font>) and Marathon Petroleum (<a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a> <font color='green'>+0.1%</font>) among refiners.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242934\" data-linked=\"HollyFrontier slapped with Sell rating at Goldman\" data-tweet=\"$HFC $HFC $VLO - HollyFrontier slapped with Sell rating at Goldman https://seekingalpha.com/news/3242934-hollyfrontier-slapped-sell-rating-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3242934-hollyfrontier-slapped-sell-rating-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242919\" data-ts=\"1487009237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARKR\" target=\"_blank\">ARKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242919-ark-restaurants-breaks-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ark Restaurants breaks higher after earnings</a></h4><ul><li>Ark Restaurants (<a href='https://seekingalpha.com/symbol/ARKR' title='Ark Restaurants Corp.'>ARKR</a> <font color='green'>+8.5%</font>) trades higher after posting Q4 results.</li><li>The company reports same store sales increased 2.7% during the quarter to top the industry average.</li><li>Ark doubled its operating income to over $1.3M.</li><li>Shares trade at their highest level in over a month.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242657-ark-restaurants-reports-fq1-results\" target=\"_blank\">Ark Restaurants reports FQ1 results</a> (Feb. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3242919\" data-linked=\"Ark Restaurants breaks higher after earnings\" data-tweet=\"$ARKR - Ark Restaurants breaks higher after earnings https://seekingalpha.com/news/3242919-ark-restaurants-breaks-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3242919-ark-restaurants-breaks-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242918\" data-ts=\"1487008840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242918-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FBC' title='Flagstar Bancorp, Inc.'>FBC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SBCF' title='Seacoast Banking Corporation of Florida'>SBCF</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SBBX' title='Sussex Bancorp'>SBBX</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FCCO' title='First Community Corporation'>FCCO</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242918\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$FBC $SBCF $SBBX - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3242918-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3242918-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242915\" data-ts=\"1487008593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWAGY\" target=\"_blank\">VWAGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242915-mobileyeplus-8_2-broad-ranging-cooperation-volkswagen-announced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mobileye +8.2%; broad-ranging cooperation with Volkswagen announced</a></h4><ul><li>Volkswagen (VLKAY) and Mobileye (NYSE:<a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a>) target implementation of <a href=\"http://www.volkswagen-media-services.com/en/detailpage/-/detail/Swarm-data-paves-way-for-autonomous-driving-Volkswagen-and-Mobileye-sign-agreement/view/4560918/7a5bbec13158edd433c6630f5ac445da?p_p_auth=J0wAjlEk\" target=\"_blank\">\"a new navigation standard for autonomous driving\"</a> beginning in 2018.</li><li>Future Volkswagen models are planned for utilization of Mobileye's <a href=\"http://www.mobileye.com/our-technology/rem/\" target=\"_blank\">Road Experience Management</a> technology, with eventual joint collection of crowd-sourced (swarm) data for advanced mapping purposes also intended.</li><li>Earlier (February 13, 2017):&nbsp;<a href=\"https://seekingalpha.com/news/3242903-mobileye-plus-6_37-percent-arrangement-volkswagen-reported\" target=\"_blank\">Mobileye +6.37%; arrangement with Volkswagen reported [updated]</a></li><li>Previously (September 14, 2016): <a href=\"https://seekingalpha.com/news/3208753-mobileye-expects-self-driving-car-deals-coming-months\" target=\"_blank\">Mobileye expects further self-driving car deals in coming months</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242915\" data-linked=\"Mobileye +8.2%; broad-ranging cooperation with Volkswagen announced\" data-tweet=\"$VWAGY $VWAGY $MBLY - Mobileye +8.2%; broad-ranging cooperation with Volkswagen announced https://seekingalpha.com/news/3242915-mobileyeplus-8_2-broad-ranging-cooperation-volkswagen-announced?source=tweet\" data-url=\"https://seekingalpha.com/news/3242915-mobileyeplus-8_2-broad-ranging-cooperation-volkswagen-announced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242913\" data-ts=\"1487008438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242913-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+94%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='green'>+81%</font>. <a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/XOMA' title='XOMA Corporation'>XOMA</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/RTK' title='Rentech, Inc'>RTK</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/RELV' title='Reliv&#39; International, Inc.'>RELV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> SGNL <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/KNL' title='Knoll, Inc.'>KNL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/PPSI' title='Pioneer Power Solutions, Inc.'>PPSI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DPRX' title='Dipexium Pharmaceuticals, LLC'>DPRX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/INOV' title='Inovalon'>INOV</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242913\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ZSAN $SINO $PLX - Midday Gainers / Losers https://seekingalpha.com/news/3242913-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3242913-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242912\" data-ts=\"1487008191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242912-biolinerx-perks-up-7-on-rodman-bullish-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx perks up 7% on Rodman bullish call</a></h4><ul><li>Thinly traded nano cap BioLineRx (<a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a> <font color='green'>+7.3%</font>) is up on more than a 4x surge in volume on the heels of Rodman &amp; Renshaw's initiation of coverage with a Buy rating and $3 (154% upside) price target.</li><li>The company's lead product candidate is Phase 2-stage cancer therapeutic BL-8040.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242912\" data-linked=\"BioLineRx perks up 7% on Rodman bullish call\" data-tweet=\"$BLRX - BioLineRx perks up 7% on Rodman bullish call https://seekingalpha.com/news/3242912-biolinerx-perks-up-7-on-rodman-bullish-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3242912-biolinerx-perks-up-7-on-rodman-bullish-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242910\" data-ts=\"1487008011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SD\" target=\"_blank\">SD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242910-sandridge-energyplus-2-after-refinancing-credit-facility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SandRidge Energy +2% after refinancing credit facility</a></h4><ul><li>SandRidge Energy (<a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color='green'>+2%</font>) is higher after saying it entered into a <a href=\"https://seekingalpha.com/pr/16740022-sandridge-energy-inc-announces-new-600-million-reserve-based-credit-facility-425-million\" target=\"_blank\">new $600M reserve based credit facility</a>, replacing a $425M revolver, with a $425M borrowing base.</li><li>The agreement also eliminates certain negative covenants, such as the PDP asset coverage  ratio, $20M minimum liquidity requirement and  limitations on capital expenditures.</li><li>SD emerged from Chapter 11 bankruptcy just <a href=\"https://seekingalpha.com/news/3212358-sandridge-energy-emerges-bankruptcy\" target=\"_blank\">four months ago</a>, and the new credit facility is another step for the company in returning to growth.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242910\" data-linked=\"SandRidge Energy +2% after refinancing credit facility\" data-tweet=\"$SD - SandRidge Energy +2% after refinancing credit facility https://seekingalpha.com/news/3242910-sandridge-energyplus-2-after-refinancing-credit-facility?source=tweet\" data-url=\"https://seekingalpha.com/news/3242910-sandridge-energyplus-2-after-refinancing-credit-facility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242909\" data-ts=\"1487007561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELMD\" target=\"_blank\">ELMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242909-electromed-up-21-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Electromed up 21% on heavy volume</a></h4><ul><li>Thinly traded nano cap Electromed (<a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='green'>+21.4%</font>) heads north on more than a 7x surge in volume. No particular news accounts for the action other than being a member of the group of tiny companies showing occasional large spikes in price/volume. Many times this behavior presages an equity offering.</li><li>The company reported fiscal Q2 results on February 8. Its cash balance as of the end of December was ~$4.8M, but cash flow from operations was modestly higher ($38.7K) for the six-month period.</li><li>Notable was its accounts receivable balance of ~$8.3M, almost 30% higher that FQ2's revenues of ~$6.4M.</li><li>The Simi Valley, CA-based company develops products that provide airway clearance therapy, such as its SmartVest System.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3096246-electromed-47-percent-premarket-fiscal-q2-results\" target=\"_blank\">Electromed up 47% premarket on fiscal Q2 results</a> (Feb. 10, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3242909\" data-linked=\"Electromed up 21% on heavy volume\" data-tweet=\"$ELMD - Electromed up 21% on heavy volume https://seekingalpha.com/news/3242909-electromed-up-21-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3242909-electromed-up-21-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242908\" data-ts=\"1487007137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242908-tire-stocks-move-higher-on-positive-pricing-read\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tire stocks move higher on positive pricing read</a></h4><ul>     <li>Tire stocks Goodyear Tire &amp; Rubber (<a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a> <font color='green'>+4%</font>) and Cooper Tire &amp; Rubber (<a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a> <font color='green'>+2.1%</font>) are making solid gains today.</li>     <li>Bloomberg attributes the rally to positive comments from Ebest Investment analyst Ji-Woong Yoo on pricing.</li><li>Michelin (<a href='https://seekingalpha.com/symbol/MGDDY' title='Michelin Cie Des Estb ADR'>OTCPK:MGDDY</a>, [[]MGDDT]) rose over 2% in Paris trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242908\" data-linked=\"Tire stocks move higher on positive pricing read\" data-tweet=\"$GT $GT $CTB - Tire stocks move higher on positive pricing read https://seekingalpha.com/news/3242908-tire-stocks-move-higher-on-positive-pricing-read?source=tweet\" data-url=\"https://seekingalpha.com/news/3242908-tire-stocks-move-higher-on-positive-pricing-read\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242907\" data-ts=\"1487007114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCP\" target=\"_blank\">HCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242907-hcpplus-1_4-after-beat-unchanged-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCP +1.4% after beat, unchanged guidance</a></h4><ul><li>Q4 adjusted FFO of $276.2M or $0.59 per share vs. $374.9M and $0.80 a year ago. There was the QCP spinoff though. Comparable AFFO per share of $0.53 compares to $0.51 in Q4 one year ago.</li><li>Dividend is $0.37.</li><li>Full-year AFFO per share guidance of $1.89-$1.95, with same-property cash NOI growth of 2.5-3.5%. Both ranges are unchanged from guidance first issued in November.</li><li>After an early dip, <a href='https://seekingalpha.com/symbol/HCP' title='HCP, Inc.'>HCP</a> now&nbsp;<font color='green'>higher by 1.4%&nbsp;</font>on the session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242794-hcp-beats-0_02-beats-revenue\" target=\"_blank\">HCP beats by $0.02, beats on revenue</a> (Feb. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3242907\" data-linked=\"HCP +1.4% after beat, unchanged guidance\" data-tweet=\"$HCP $PEAK - HCP +1.4% after beat, unchanged guidance https://seekingalpha.com/news/3242907-hcpplus-1_4-after-beat-unchanged-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3242907-hcpplus-1_4-after-beat-unchanged-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242905\" data-ts=\"1487006572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242905-occidental-petro-cut-mizuho-dividend-yield-insufficient-for-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petro cut at Mizuho as dividend yield insufficient for upside</a></h4><ul>     <li>Occidental Petroleum (<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-1.9%</font>) is lower as Mizuho <a href=\"http://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Upgrades+Occidental+Petroleum+%28OXY%29+to+Neutral/12531469.html\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with a $70 price target, cut from $87, believing OXY can continue growing its dividend but only  at a modest pace, and seeing \"few idiosyncratic drivers of stock  outperformance.\"</li><li>Mizuho cites OXY's rich relative valuation, increasing unit expenses trends through 2016, muted  dividend growth and and deteriorating debt and leverage metrics relative to historical standards.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242905\" data-linked=\"Occidental Petro cut at Mizuho as dividend yield insufficient for upside\" data-tweet=\"$OXY - Occidental Petro cut at Mizuho as dividend yield insufficient for upside https://seekingalpha.com/news/3242905-occidental-petro-cut-mizuho-dividend-yield-insufficient-for-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3242905-occidental-petro-cut-mizuho-dividend-yield-insufficient-for-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242903\" data-ts=\"1487005996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWAGY\" target=\"_blank\">VWAGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242903-mobileyeplus-6_37-arrangement-volkswagen-reported-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mobileye +6.37%; arrangement with Volkswagen reported [updated]</a></h4><ul><li>Volkswagen (VLKAY) cooperation involving Mobileye's Road Experience Management [REM] system&nbsp;<a href=\"http://www.reuters.com/article/idUSFWN1FY0WC\" target=\"_blank\">noted</a>.</li><li>Mobileye (NYSE:<a href='https://seekingalpha.com/symbol/MBLY' title='Mobileye'>MBLY</a>) $46.08.</li><li><strong>Update</strong>: A prior-expected collaboration&nbsp;<a href=\"https://seekingalpha.com/news/3242915-mobileye-plus-8_2-percent-broad-ranging-cooperation-volkswagen-announced\" target=\"_blank\">formally announced</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242903\" data-linked=\"Mobileye +6.37%; arrangement with Volkswagen reported [updated]\" data-tweet=\"$VWAGY $VWAGY $MBLY - Mobileye +6.37%; arrangement with Volkswagen reported [updated] https://seekingalpha.com/news/3242903-mobileyeplus-6_37-arrangement-volkswagen-reported-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3242903-mobileyeplus-6_37-arrangement-volkswagen-reported-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242897\" data-ts=\"1487005415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGEN\" target=\"_blank\">MGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242897-signal-stockholders-ok-all-miragen-merger-related-proposals-shares-ease-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signal stockholders OK all Miragen merger-related proposals; shares ease 21%</a></h4><ul><li>Thinly traded nano cap Signal Genetics (SGNL <font color='red'>-20.9%</font>) drops on more than a 50% surge in volume, albeit on turnover of only 81K shares, in response to its <a href=\"https://seekingalpha.com/pr/16739652-signal-announces-results-special-meeting\" target=\"_blank\">announcement </a>that all Miragen merger-related proposals were approved by stockholders at Friday's special meeting. Miragen stockholders will receive ~0.7031 of a share of Signal for each Miragen share owned.</li><li>The proposals included the issuance of common stock, the change in control, the change in name to Miragen Therapeutics, a 1:15 reverse stock split, an increase in the number of authorized shared of Signal common to 100M from 50M and the sale of MyPRS assets to Quest Diagnostics.</li><li>At the closing of the merger, Miragen is expected to receive gross proceeds of $40.7M from investors, increasing the cash balance for the combined firm to ~$61.7M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242897\" data-linked=\"Signal stockholders OK all Miragen merger-related proposals; shares ease 21%\" data-tweet=\"$MGEN - Signal stockholders OK all Miragen merger-related proposals; shares ease 21% https://seekingalpha.com/news/3242897-signal-stockholders-ok-all-miragen-merger-related-proposals-shares-ease-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3242897-signal-stockholders-ok-all-miragen-merger-related-proposals-shares-ease-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242898\" data-ts=\"1487005002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242898-report-brazil-politics-keep-ferreira-vale-ceo-for-two-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Brazil politics could keep Ferreira as Vale CEO for two more years</a></h4><ul>     <li>Vale's (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+7.9%</font>) top non-government shareholders want CEO Murilo Ferreira to <a href=\"http://www.reuters.com/article/vale-sa-ceo-idUSL1N1FY0GR\" target=\"_blank\">stay in his job for another two years</a> to stem pressure from Brazilian politicians to appoint an ally, Reuters reports, citing newspaper Valor Econ&ocirc;mico.</li>     <li>Members of Brazilian Pres. Temer's PMDB party and Senator Neves of the PSDB party from the mineral-rich Minas Gerais state, where Vale is based, have been vying for months to influence the selection of the new CEO, according to the report.</li>     <li>The tension over the Vale job is the latest sign of strain between the two biggest parties in Temer's coalition, as the PSDB and some in Temer's PMDB have clashed over a string of ministry posts and may run rival candidates in Brazil's 2018 presidential election.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242898\" data-linked=\"Report: Brazil politics could keep Ferreira as Vale CEO for two more years\" data-tweet=\"$VALE - Report: Brazil politics could keep Ferreira as Vale CEO for two more years https://seekingalpha.com/news/3242898-report-brazil-politics-keep-ferreira-vale-ceo-for-two-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3242898-report-brazil-politics-keep-ferreira-vale-ceo-for-two-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242896\" data-ts=\"1487004388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242896-ubs-reissues-apple-buy-considers-services-undervalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS reissues Apple at Buy, considers Services undervalued</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Apple+%28AAPL%29+%24138+PT+and+Buy+Rating+Maintained+at+UBS%3B+Services+Business+Undervalued/12533502.html\" target=\"_blank\">Analyst Steve Milunovich</a>: \"Management has emphasized the importance of services the past year. We consider the installed base and retention rate the primary drivers of device and services value. We also view Apple as a platform vendor with hardware and services intertwined. However, to test the notion that the market underappreciates services, we performed a sum-of-the-parts analysis. If Apple services were valued similarly to PayPal, the stock would be at least 10% higher.\" Price target $138 (current price $133.64).</li><li>A strengthening component of Apple's (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+1.2%</font>) business, Services is projected (<a href=\"https://seekingalpha.com/article/4041266-apple-aapl-q1-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">by Apple</a>) to represent the size of Fortune 100 this year and is targeted to double in size over the next four.</li><li>Previously (February 10, 2017):&nbsp;<a href=\"https://seekingalpha.com/news/3242639-bernstein-reiterates-apple-outperform-addresses-services\" target=\"_blank\">Bernstein reiterates Apple at Outperform, addresses Services</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242896\" data-linked=\"UBS reissues Apple at Buy, considers Services undervalued\" data-tweet=\"$AAPL - UBS reissues Apple at Buy, considers Services undervalued https://seekingalpha.com/news/3242896-ubs-reissues-apple-buy-considers-services-undervalued?source=tweet\" data-url=\"https://seekingalpha.com/news/3242896-ubs-reissues-apple-buy-considers-services-undervalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242893\" data-ts=\"1487003240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAB\" target=\"_blank\">CAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242893-gander-mountain-said-to-be-close-to-bankruptcy-filing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gander Mountain said to be close to bankruptcy filing</a></h4><ul> <li>Gander Mountain is close to <a href=\"http://www.reuters.com/article/gandermountain-bankruptcy-idUSL1N1FV1O2\" target=\"_blank\">filing</a> for bankruptcy, according to Reuters.</li> <li>Sources indicate that a filing from the company could arrive as early as this month.</li><li>The Minneapolis-based Gander has 152 locations spread across 26 states.</li> <li>The development could be a positive for Cabela's (<a href='https://seekingalpha.com/symbol/CAB' title='Cabela&#39;s Incorporated'>CAB</a> <font color='green'>+1.1%</font>), Sportsman's Warehouse Holdings (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-5.1%</font>) and Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='green'>+0.1%</font>) after some short-term pain from liquidation sales.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242893\" data-linked=\"Gander Mountain said to be close to bankruptcy filing\" data-tweet=\"$CAB $CAB $SPWH - Gander Mountain said to be close to bankruptcy filing https://seekingalpha.com/news/3242893-gander-mountain-said-to-be-close-to-bankruptcy-filing?source=tweet\" data-url=\"https://seekingalpha.com/news/3242893-gander-mountain-said-to-be-close-to-bankruptcy-filing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242892\" data-ts=\"1487003171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242892-protalix-continues-up-move-shares-ahead-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix continues up move, shares ahead 27%</a></h4><ul><li>Micro cap Protalix BioTherapeutics (<a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a> <font color='green'>+26.7%</font>) shows that its up move still has legs. Shares are up on almost a 5x surge in volume. The party started in early January when the company announced positive preliminary data from a mid-stage study assessing AIR DNase (alidornase alfa) in cystic fibrosis patients. Shares have more than tripled since then.</li><li>This week the company will <a href=\"https://seekingalpha.com/pr/16739996-protalix-biotherapeutics-participate-13th-annual-worldsymposium-2017\" target=\"_blank\">participate </a>in the 13th Annual WORLDSymposium in San Diego, CA, presenting data on PRX-102 in Fabry disease.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233063-protalix-bios-cf-candidate-shows-encouraging-results-mid-stage-study-shares-5-percent\" target=\"_blank\">Protalix Bio's CF candidate shows encouraging results in mid-stage study; shares up 5% premarket</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3242892\" data-linked=\"Protalix continues up move, shares ahead 27%\" data-tweet=\"$PLX - Protalix continues up move, shares ahead 27% https://seekingalpha.com/news/3242892-protalix-continues-up-move-shares-ahead-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3242892-protalix-continues-up-move-shares-ahead-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242888\" data-ts=\"1487001789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNL\" target=\"_blank\">KNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242888-knollminus-11-after-revenue-shortfall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knoll -11% after revenue shortfall</a></h4><ul> <li>Knoll (<a href='https://seekingalpha.com/symbol/KNL' title='Knoll, Inc.'>KNL</a> <font color='red'>-10.8%</font>) trades lower after Q4 revenue falls short of estimates.</li> <li>\"While we were impacted in the fourth quarter by the slowdown in demand that has been sweeping across the industry, we see reasons to be hopeful that with the uncertainty of the presidential election behind us, demand should improve later in the year,\" notes CEO Andrew Cogan.</li> <li>The company's gross margin rate of 38.0% for the quarter met expectations.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242656-knoll-eps-line-misses-revenue\" target=\"_blank\">Knoll EPS in-line, misses on revenue</a> (Feb. 10)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242888\" data-linked=\"Knoll -11% after revenue shortfall\" data-tweet=\"$KNL - Knoll -11% after revenue shortfall https://seekingalpha.com/news/3242888-knollminus-11-after-revenue-shortfall?source=tweet\" data-url=\"https://seekingalpha.com/news/3242888-knollminus-11-after-revenue-shortfall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242855\" data-ts=\"1487001619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242855-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/ELMD' title='Electromed, Inc.'>ELMD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/XOMA' title='XOMA Corporation'>XOMA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> SGNL <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DPRX' title='Dipexium Pharmaceuticals, LLC'>DPRX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242855\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$ZSAN $PLX $ELMD - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3242855-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3242855-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242881\" data-ts=\"1487000960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242881-oracle-files-appeal-of-may-2016-decision-regarding-java-dispute-google\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle files appeal of May 2016 decision regarding Java dispute with Google</a></h4><ul><li>Having originally sued Google (<a href=\"https://seekingalpha.com/symbol/GOOG/focus\" target=\"_blank\">GOOG</a>, <a href=\"https://seekingalpha.com/symbol/GOOGL/focus\" target=\"_blank\">GOOGL</a>) in 2010 alleging infringement over the use of Java code in the Android operating system, Oracle (<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='green'>+0.5%</font>) revives the suit, most recently ruled in Google's favor in May of last year, appealing that latest development.</li><li>Oracle had been seeking $9B, denied in the 2016 decision.</li><li><a href=\"https://qz.com/908485/oracle-appeals-decision-that-google-did-not-infringe-java-api-copyright/\" target=\"_blank\">Timeline</a> [Quartz]</li></ul><div class=\"tiny-share-widget\" data-id=\"3242881\" data-linked=\"Oracle files appeal of May 2016 decision regarding Java dispute with Google\" data-tweet=\"$ORCL $GOOG $GOOGL - Oracle files appeal of May 2016 decision regarding Java dispute with Google https://seekingalpha.com/news/3242881-oracle-files-appeal-of-may-2016-decision-regarding-java-dispute-google?source=tweet\" data-url=\"https://seekingalpha.com/news/3242881-oracle-files-appeal-of-may-2016-decision-regarding-java-dispute-google\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242880\" data-ts=\"1487000761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242880-nucor-upgraded-ak-steel-downgraded-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor upgraded, AK Steel downgraded at Morgan Stanley</a></h4><ul><li>Steelmakers are rallying as China reportedly <a href=\"https://seekingalpha.com/news/3242821-reuters-china-might-force-aluminum-steel-producers-cut-output\" target=\"_blank\">considers cutting production</a> to fight smog, and Nucor (<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+3.6%</font>) shares are enjoying the extra benefit of receiving an <a href=\"http://www.investors.com/news/weibo-and-momo-are-buys-nucor-upgraded-panera-pt-hiked/\" target=\"_blank\">upgrade</a> to Overweight from Equal Weight with a $78 price target at Morgan Stanley.</li><li>Stanley analyst Evan Kurtz sees a \"couple of trade case-related catalysts,\" with  the Trump administration expected to apply tariffs on additional  categories of Chinese steel, and expects the construction market, which  accounts for more than half of NUE's shipments, growing 4% this year.</li><li>Kurtz says that while NUE would benefit from a favorable ruling on ongoing rebar and plate trade cases, he is concerned that AK Steel&rsquo;s (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+0.2%</font>) electrical steel exposure, heavy auto steel exposure may become headwinds in 2017, and he downgrades the stock to Equal Weight from Overweight with an $11 price target.</li><li>Kurtz says his scrap steel contacts expect a rebound in the scrap market, and steel-buyer  contacts see healthy U.S. supply and demand; he expects utilization to reach 80% in 2017 vs. 73% in 2016, which he thinks may lead to another round of mill price hikes.</li><li>The firm retains its Overweight ratings on U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+5.9%</font>) and Steel Dynamics (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+3.1%</font>); <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color='green'>+3.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242880\" data-linked=\"Nucor upgraded, AK Steel downgraded at Morgan Stanley\" data-tweet=\"$NUE $NUE $AKS - Nucor upgraded, AK Steel downgraded at Morgan Stanley https://seekingalpha.com/news/3242880-nucor-upgraded-ak-steel-downgraded-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3242880-nucor-upgraded-ak-steel-downgraded-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242879\" data-ts=\"1487000677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242879-new-science-chief-infinity-pharma-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New science chief at Infinity Pharma; shares ahead 8%</a></h4><ul><li>Infinity Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>)&nbsp;heads north in early trading on increased volume. The only news today was the <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=121941&amp;p=irol-newsArticle&amp;ID=2245483\" target=\"_blank\">promotion </a>of VP, biology and translational science Jeffrey Kutok, M.D., Ph.D., to chief scientific officer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242879\" data-linked=\"New science chief at Infinity Pharma; shares ahead 8%\" data-tweet=\"$INFY - New science chief at Infinity Pharma; shares ahead 8% https://seekingalpha.com/news/3242879-new-science-chief-infinity-pharma-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3242879-new-science-chief-infinity-pharma-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242877\" data-ts=\"1487000382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAI\" target=\"_blank\">RAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242877-rbc-capital-calls-top-on-reynolds-american\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC Capital calls a top on Reynolds American</a></h4><ul> <li>RBC Capital Markets downgrades Reynolds American (<a href='https://seekingalpha.com/symbol/RAI' title='Reynolds American, Inc.'>RAI</a> <font color='green'>+0.1%</font>) to Sector Perform from Outperform on its view that valuation on the tobacco stock has now been played out.</li> <li>The investment firm adjusts its price target to $60 from $54.</li> <li>Shares of RAI are up 27% over the last 52 weeks and reached a high point of $60.91 last week,</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242877\" data-linked=\"RBC Capital calls a top on Reynolds American\" data-tweet=\"$RAI - RBC Capital calls a top on Reynolds American https://seekingalpha.com/news/3242877-rbc-capital-calls-top-on-reynolds-american?source=tweet\" data-url=\"https://seekingalpha.com/news/3242877-rbc-capital-calls-top-on-reynolds-american\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242872\" data-ts=\"1486999654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242872-gilead-perks-up-on-activist-chatter-shares-up-1-from-intraday-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead perks up on activist chatter; shares up 1% from intraday low</a></h4><ul><li>Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='green'>+1.2%</font>) shows some life in early trading on chatter that activist investor Carl Icahn may be mulling an investment. Shares have lost 13% of their value since early January and almost 42% of their value since mid-2015.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242872\" data-linked=\"Gilead perks up on activist chatter; shares up 1% from intraday low\" data-tweet=\"$GILD - Gilead perks up on activist chatter; shares up 1% from intraday low https://seekingalpha.com/news/3242872-gilead-perks-up-on-activist-chatter-shares-up-1-from-intraday-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3242872-gilead-perks-up-on-activist-chatter-shares-up-1-from-intraday-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242870\" data-ts=\"1486999262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMED\" target=\"_blank\">OMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242870-oncomeds-early-stage-study-of-anti-dll4-vegf-bispecific-antibody-in-treatment-resistant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoMed&#39;s early-stage study of anti-DLL4/VEGF bispecific antibody in treatment-resistant ovarian cancer underway; shares up 2%</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16740232-oncomed-enrolls-first-patient-phase-1b-clinical-trial-anti-dll4-vegf-bispecific-antibody\" target=\"_blank\">first patient has been dosed</a> in a Phase 1b clinical trial assessing OncoMed Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/OMED' title='OncoMed Pharmaceuticals, Inc'>OMED</a> <font color='green'>+1.6%</font>) anti-DLL4/VEGF bispecific antibody, OMP-305B83, combined with the chemo agent paclitaxel, in patients with platinum-resistant ovarian cancer.</li><li>According to ClinicalTrials.gov, the estimated final data collection date for the primary endpoints, safety measurements, is June 2019. The estimated study completion date is December 2019.</li><li>OMP-305B83 is designed to induce an anti-tumor response with less unwanted side effects by inhibiting proteins DLL4 and VEGF. It was developed with the company's BiMAb platform and is part of its collaboration with Celgene.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242870\" data-linked=\"OncoMed&#39;s early-stage study of anti-DLL4/VEGF bispecific antibody in treatment-resistant ovarian cancer underway; shares up 2%\" data-tweet=\"$OMED - OncoMed&#39;s early-stage study of anti-DLL4/VEGF bispecific antibody in treatment-resistant ovarian cancer underway; shares up 2% https://seekingalpha.com/news/3242870-oncomeds-early-stage-study-of-anti-dll4-vegf-bispecific-antibody-in-treatment-resistant?source=tweet\" data-url=\"https://seekingalpha.com/news/3242870-oncomeds-early-stage-study-of-anti-dll4-vegf-bispecific-antibody-in-treatment-resistant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242869\" data-ts=\"1486999232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242869-deutsche-bank-reissues-acacia-communications-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank reissues Acacia Communications at Buy</a></h4><ul><li>Citing positive industry checks and sound end-market signals observed through peers, <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Says+Buy+Acacia+Communications+%28ACIA%29+Into+Its+Q4+Print/12532759.html\" target=\"_blank\">analyst Vijay Bhagavath</a> expects modest beat-and-raise results to post when Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) reports Q4 2016 earnings on <a href=\"http://ir.acacia-inc.com/phoenix.zhtml?c=254242&amp;p=irol-eventDetails&amp;EventId=5247761\" target=\"_blank\">February 23</a>,&nbsp;compared to conservative consensus projections.</li><li>Reiterates $125 target (current price $58.67,&nbsp;<font color='green'>+4.73%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3242869\" data-linked=\"Deutsche Bank reissues Acacia Communications at Buy\" data-tweet=\"$ACIA - Deutsche Bank reissues Acacia Communications at Buy https://seekingalpha.com/news/3242869-deutsche-bank-reissues-acacia-communications-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3242869-deutsche-bank-reissues-acacia-communications-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242861\" data-ts=\"1486998070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DMPI\" target=\"_blank\">DMPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242861-delmars-phase-2-study-assessing-valminus-083-in-brain-cancer-underway-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DelMar&#39;s Phase 2 study assessing VAL-083 in brain cancer underway; shares up 3%</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16740268-delmar-pharmaceuticals-announces-dosing-first-patient-phase-two-clinical-trial-valminus-083\" target=\"_blank\">first patient has been dosed</a> in a 48-subject Phase 2 clinical trial assessing DelMar Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='green'>+2.6%</font>) lead product candidate VAL-083 in patients with MGMT-unmethylated Avastin (bevacizumab)-naive recurrent glioblastoma &#40;GBM&#41;.</li><li>According to ClinicalTrials.gov, the estimated final data collection date for the primary endpoint, overall survival, is September 2020. The estimated study completion date is June 2021.</li><li>About 2/3 of newly diagnosed GBM patients have tumors with an unmethylated MGMT promoter which is correlated with high expression of MGMT, a DNA repair enzyme. These patients have a poor prognosis and are resistant to treatment with alkylating agents like temozolomide, carmustine and lomustin.</li><li><a href=\"http://www.delmarpharma.com/pipeline.html\" target=\"_blank\">VAL-083</a>&nbsp;is a small molecule chemotherapeutic, specifically a bi-functional alkylating agent.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242861\" data-linked=\"DelMar&#39;s Phase 2 study assessing VAL-083 in brain cancer underway; shares up 3%\" data-tweet=\"$DMPI - DelMar&#39;s Phase 2 study assessing VAL-083 in brain cancer underway; shares up 3% https://seekingalpha.com/news/3242861-delmars-phase-2-study-assessing-valminus-083-in-brain-cancer-underway-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3242861-delmars-phase-2-study-assessing-valminus-083-in-brain-cancer-underway-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242860\" data-ts=\"1486998051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMRE\" target=\"_blank\">CMRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242860-costamare-tracks-higher-after-analyst-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costamare tracks higher after analyst upgrades</a></h4><ul> <li>Costamare (<a href='https://seekingalpha.com/symbol/CMRE' title='Costamare Inc.'>CMRE</a> <font color='green'>+6.8%</font>)&nbsp;rallies after a pair of analyst upgrades.</li> <li>Wells Fargo takes Costamare up to Outperform from Market Perform.</li> <li>Stifel Nicolaus goes to a <a href=\"https://twitter.com/usratings/status/831112518852628481\" target=\"_blank\">Hold stance</a> from Sell on its view that valuation is now reasonable due to container shipping fundamentals.</li> <li>Shares of Costamare are at a two-week high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242860\" data-linked=\"Costamare tracks higher after analyst upgrades\" data-tweet=\"$CMRE - Costamare tracks higher after analyst upgrades https://seekingalpha.com/news/3242860-costamare-tracks-higher-after-analyst-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3242860-costamare-tracks-higher-after-analyst-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242856\" data-ts=\"1486997547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242856-delta-to-increase-stake-in-grupo-aeromexico\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta to increase stake in Grupo Aeromxico</a></h4><ul>     <li>Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='green'>+0.7%</font>) discloses that it intends to acquire more shares of Grupo Aerom&eacute;xico (<a href='https://seekingalpha.com/symbol/GRPAF' title='Grupo Aeromexico SAB DE CV'>OTCPK:GRPAF</a>) through a cash tender offer at MXP$43.59 per share. The new purchases could account for as high as 32% of outstanding Grupo shares.</li>     <li>The company says the investment will strengthen the partnership between the two carriers.</li>     <li>Delta currently holds a &nbsp;~4.1% stake in Grupo Aerom&eacute;xico and has an option to acquire an additional 8.1%. Separately, the Delta pension trust holds options to acquire approximately 4.6%&nbsp;of Grupo Aerom&eacute;xico.</li>     <li>Following completion of the above-referenced tender offer, Delta and the Delta pension trust collectively would own and/or have options to acquire up to a total of 49%&nbsp;of the outstanding shares of Grupo Aerom&eacute;xico.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16740286-delta-announces-intention-acquire-additional-shares-grupo-aeromexico\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3242856\" data-linked=\"Delta to increase stake in Grupo Aeromxico\" data-tweet=\"$DAL $DAL $GRPAF - Delta to increase stake in Grupo Aeromxico https://seekingalpha.com/news/3242856-delta-to-increase-stake-in-grupo-aeromexico?source=tweet\" data-url=\"https://seekingalpha.com/news/3242856-delta-to-increase-stake-in-grupo-aeromexico\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242853\" data-ts=\"1486997231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUO\" target=\"_blank\">AUO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242853-au-optronicsminus-6_43-downgraded-to-underweight-j-p-morgan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AU Optronics -6.43%; downgraded to Underweight at J.P. Morgan</a></h4><ul><li>Analyst Narci&nbsp;Chang, <a href=\"http://blogs.barrons.com/asiastocks/2017/02/12/lcd-industry-to-turn-sour-again-jp-morgan-downgrade/\" target=\"_blank\">estimating LCD&nbsp;display capacity</a> supply growth at 3%, 6% and 11%, respectively, for 2017, 2018 and 2019 compared to estimated demand growth at 4% for each,&nbsp;reduces <a href=\"http://www.streetinsider.com/Downgrades/JPMorgan+Downgrades+AU+Optronics+%28AUO%29+to+Underweight/12532635.html\" target=\"_blank\">from Neutral</a> prior.</li><li>AU Optronics (NYSE:<a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a>) $3.71.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242853\" data-linked=\"AU Optronics -6.43%; downgraded to Underweight at J.P. Morgan\" data-tweet=\"$AUO - AU Optronics -6.43%; downgraded to Underweight at J.P. Morgan https://seekingalpha.com/news/3242853-au-optronicsminus-6_43-downgraded-to-underweight-j-p-morgan?source=tweet\" data-url=\"https://seekingalpha.com/news/3242853-au-optronicsminus-6_43-downgraded-to-underweight-j-p-morgan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242843\" data-ts=\"1486995623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242843-big-four-wireless-lower-after-verizon-returns-to-unlimited-well\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big four wireless lower after Verizon returns to unlimited well</a></h4><ul>   <li>U.S. big four wireless stocks are trading down premarket as Verizon's move <a href=\"https://seekingalpha.com/news/3242721-verizon-brings-back-unlimited-data\" target=\"_blank\">back into unlimited data plans</a> portends no letdown in hot competition between the four.</li>    <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) is making the biggest move in the early session, <font color='red'>down 3.1%</font> with well over a quarter-million shares traded. It may be suffering most as it had begun marking gains against rivals alongside its own unlimited offering.</li>    <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) is <font color='red'>off 1.5%</font> with nearly 150,000 shares traded. Meanwhile, AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) is <font color='red'>down 1.2%</font> with just under 100,000 shares traded, and smaller rival T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) is <font color='red'>1.7% lower</font> in lighter volume.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242843\" data-linked=\"Big four wireless lower after Verizon returns to unlimited well\" data-tweet=\"$S $S $VZ - Big four wireless lower after Verizon returns to unlimited well https://seekingalpha.com/news/3242843-big-four-wireless-lower-after-verizon-returns-to-unlimited-well?source=tweet\" data-url=\"https://seekingalpha.com/news/3242843-big-four-wireless-lower-after-verizon-returns-to-unlimited-well\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242841\" data-ts=\"1486995541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELOS\" target=\"_blank\">ELOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242841-syneron-gets-zeltiq-stoked-boost-shares-ahead-15-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syneron gets ZELTIQ-stoked boost; shares ahead 15% premarket</a></h4><ul><li>Allergan's $2.47B takeout of ZELTIQ Aesthetics stokes modest buying in <a href=\"http://syneron-candela.com/na\" target=\"_blank\">Syneron Medical</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/ELOS' title='Syneron Medical Ltd.'>ELOS</a>), a maker of lasers used in aesthetic procedures such as body contouring (fat removal). Shares are up&nbsp;<font color='green'>15%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242841\" data-linked=\"Syneron gets ZELTIQ-stoked boost; shares ahead 15% premarket\" data-tweet=\"$ELOS - Syneron gets ZELTIQ-stoked boost; shares ahead 15% premarket https://seekingalpha.com/news/3242841-syneron-gets-zeltiq-stoked-boost-shares-ahead-15-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242841-syneron-gets-zeltiq-stoked-boost-shares-ahead-15-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242836\" data-ts=\"1486995389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242836-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+70%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ZLTQ' title='ZELTIQ Aesthetics, Inc.'>ZLTQ</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/RTK' title='Rentech, Inc'>RTK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+7%</font>. PIP <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color='green'>+%</font>.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3242836\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$ZSAN $SINO $PLUG - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3242836-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3242836-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242834\" data-ts=\"1486995117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242834-mabvaxs-mvtminus-5873-shows-encouraging-action-in-preclinical-pancreatic-cancer-model\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax&#39;s MVT-5873 shows encouraging action in preclinical pancreatic cancer model with combined with Halozyme&#39;s PEGPH20; shares ahead 6% premarket</a></h4><ul><li>Thinly traded nano cap MabVax Therapeutics Holdings (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a>) is up&nbsp;<font color='green'>6%&nbsp;</font>premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16740218-mabvax-therapeutics-studies-lead-investigational-drug-mvtminus-5873-halozyme-pegph20\" target=\"_blank\">announcement&nbsp;</a>of positive results from a preclinical study assessing HuMab-5B1 antibody MVT-5873, combined with Halozyme Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a>) PEGPH20, in an animal model of pancreatic cancer. Results showed an improvement in accumulation of MVT-5873 on tumors when administered in sequence with PEGPH20.</li><li>MVT-5873 is currently in Phase 1 development to determine the recommended dose for Phase 2 studies.</li><li><a href=\"http://www.halozyme.com/technology-and-products/product-candidate/pegph20/default.aspx\" target=\"_blank\">PEGPH20</a>&nbsp;is an investigational drug administered intravenously that temporarily degrades hyaluronan, a chain of natural sugars that builds up around cancer cells inhibiting the effectiveness of cancer-killing therapies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242834\" data-linked=\"MabVax&#39;s MVT-5873 shows encouraging action in preclinical pancreatic cancer model with combined with Halozyme&#39;s PEGPH20; shares ahead 6% premarket\" data-tweet=\"$MBVX $MBVXQ $HALO - MabVax&#39;s MVT-5873 shows encouraging action in preclinical pancreatic cancer model with combined with Halozyme&#39;s PEGPH20; shares ahead 6% premarket https://seekingalpha.com/news/3242834-mabvaxs-mvtminus-5873-shows-encouraging-action-in-preclinical-pancreatic-cancer-model?source=tweet\" data-url=\"https://seekingalpha.com/news/3242834-mabvaxs-mvtminus-5873-shows-encouraging-action-in-preclinical-pancreatic-cancer-model\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242830\" data-ts=\"1486994795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRV\" target=\"_blank\">TRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242830-travelers-down-2-sell-side-bull-heads-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Travelers down 2% as sell-side bull heads to sidelines</a></h4><ul><li>Details aren't yet available, but FBR's Randy Binner has downgraded Travelers (NYSE:<a href='https://seekingalpha.com/symbol/TRV' title='The Travelers Companies, Inc.'>TRV</a>) to Market Perform from Outperform. The stock is&nbsp;<font color='green'>up 11.4%</font>&nbsp;Y/Y, with all of that and more occurring since the election.</li><li>Binner's $119 price target is roughly inline with Friday's close.</li><li>Shares are&nbsp;<font color='red'>down 2%</font>&nbsp;in premarket action to $117.31.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242830\" data-linked=\"Travelers down 2% as sell-side bull heads to sidelines\" data-tweet=\"$TRV - Travelers down 2% as sell-side bull heads to sidelines https://seekingalpha.com/news/3242830-travelers-down-2-sell-side-bull-heads-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3242830-travelers-down-2-sell-side-bull-heads-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242829\" data-ts=\"1486994417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242829-morgan-stanley-sees-fair-value-on-jcp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley sees fair value on JCP</a></h4><ul> <li>Morgan Stanley boosts J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) to Equal Weight from Underweight off a more positive view on valuation.</li> <li>The investment firm has a $7 price target on JCP, which averages out the bull case ($14 PT) and bear case ($2) scenarios.</li> <li>Shares of JCP are moving off the Morgan endearment, <font color='green'>up 2.80%</font> premarket to $7.34.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242829\" data-linked=\"Morgan Stanley sees fair value on JCP\" data-tweet=\"$JCP - Morgan Stanley sees fair value on JCP https://seekingalpha.com/news/3242829-morgan-stanley-sees-fair-value-on-jcp?source=tweet\" data-url=\"https://seekingalpha.com/news/3242829-morgan-stanley-sees-fair-value-on-jcp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242827\" data-ts=\"1486994325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242827-zosanos-lead-product-candidate-successful-in-late-stage-migraine-study-shares-ahead-46\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano&#39;s lead product candidate successful in late-stage migraine study; shares ahead 46% premarket</a></h4><ul><li>Thinly traded nano cap Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>) is up&nbsp;<font color='green'>46%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16740239-zosano-pharma-announces-3_8mg-dose-m207-novel-transdermal-therapeutic-meets-co-primary\" target=\"_blank\">announcement </a>of successful results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02745392?term=zotrip&amp;rank=1\" target=\"_blank\">ZOTRIP</a>, assessing lead product candidate M207 for the treatment of migraine. The study met both co-primary endpoints of pain freedom and most bothersome symptom freedom at hour 2.</li><li>M207 is a zolmitriptan-coated microneedle patch is that is designed to rapidly deliver zolmitriptan during a migraine attack. Zolmitriptan was marketed as a branded medicine by AstraZeneca before coming off patent several years ago.</li><li>The company is working toward an NDA filing, but has not released a time line for the submission.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242827\" data-linked=\"Zosano&#39;s lead product candidate successful in late-stage migraine study; shares ahead 46% premarket\" data-tweet=\"$ZSAN - Zosano&#39;s lead product candidate successful in late-stage migraine study; shares ahead 46% premarket https://seekingalpha.com/news/3242827-zosanos-lead-product-candidate-successful-in-late-stage-migraine-study-shares-ahead-46?source=tweet\" data-url=\"https://seekingalpha.com/news/3242827-zosanos-lead-product-candidate-successful-in-late-stage-migraine-study-shares-ahead-46\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242823\" data-ts=\"1486993996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCIX\" target=\"_blank\">DCIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242823-diana-containerships-misses-0_15-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diana Containerships misses by $0.15, misses on revenue</a></h4><ul><li>Diana Containerships (NASDAQ:<a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a>): Q4 EPS of -$0.92 <font color='red'>misses by $0.15</font>.</li><li>Revenue of $5.45M (-63.4% Y/Y) <font color='red'>misses by $2.05M</font>.</li><li>Shares <font color='green'>+6.18%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16740278-diana-containerships-inc-reports-financial-results-fourth-quarter-year-ended-december-31-2016'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242823\" data-linked=\"Diana Containerships misses by $0.15, misses on revenue\" data-tweet=\"$DCIX - Diana Containerships misses by $0.15, misses on revenue https://seekingalpha.com/news/3242823-diana-containerships-misses-0_15-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3242823-diana-containerships-misses-0_15-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242821\" data-ts=\"1486993605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242821-reuters-china-might-force-aluminum-and-steel-producers-to-cut-output\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: China might force aluminum and steel producers to cut output</a></h4><ul>     <li>Steel names (NYSEARCA:<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>) are higher premarket following a report that China might <a href=\"http://www.reuters.com/article/us-china-pollution-idUSKBN15S0ET\" target=\"_blank\">force aluminum and steel producers to cut production</a> as part of the country's war on smog; <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+5.2%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+1.4%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+1.2%</font>.</li>     <li>A government draft document outlines plans to cut steel and fertilizer capacity by at least half and aluminum capacity by at least 30% in 28 Chinese cities across five regions from late November to late February, Reuters reports.</li>     <li>Based on the cuts over three months, the measures would reduce China's total annual steel output by 8% annually and aluminum output by 17%, according to the report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242821\" data-linked=\"Reuters: China might force aluminum and steel producers to cut output\" data-tweet=\"$MT $SLX $MT - Reuters: China might force aluminum and steel producers to cut output https://seekingalpha.com/news/3242821-reuters-china-might-force-aluminum-and-steel-producers-to-cut-output?source=tweet\" data-url=\"https://seekingalpha.com/news/3242821-reuters-china-might-force-aluminum-and-steel-producers-to-cut-output\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242811\" data-ts=\"1486992557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIN\" target=\"_blank\">HAIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242811-hain-celestial-lower-amid-filing-delay-sec-subpoena\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hain Celestial lower amid filing delay, SEC subpoena</a></h4><ul> <li>Hain Celestial (NASDAQ:<a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a>) says it doesn't expect to file its quarterly report until an internal accounting review and audit process are finished.</li> <li>The company also discloses that the SEC issued a subpoena for more information on the accounting issues.</li> <li><a href=\"https://seekingalpha.com/filing/3400819\" target=\"_blank\">SEC Form 12b-25</a></li> <li>HAIN <font color='red'>-9.84%</font> premarket to $34.74. The 52-week low on Hain is $34.04.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242811\" data-linked=\"Hain Celestial lower amid filing delay, SEC subpoena\" data-tweet=\"$HAIN - Hain Celestial lower amid filing delay, SEC subpoena https://seekingalpha.com/news/3242811-hain-celestial-lower-amid-filing-delay-sec-subpoena?source=tweet\" data-url=\"https://seekingalpha.com/news/3242811-hain-celestial-lower-amid-filing-delay-sec-subpoena\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242807\" data-ts=\"1486992342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242807-global-miners-move-higher-alongside-copper-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global miners move higher alongside copper prices</a></h4><ul>     <li>Global mining stocks extend recent gains on the back of stronger metals prices, with copper rising to its <a href=\"http://www.reuters.com/article/us-global-markets-idUSKBN15R130\" target=\"_blank\">highest level since May 2015</a> as the world's two biggest mines face production stoppages.</li>     <li>Shares in BHP&nbsp;Billiton (NYSE:<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a>), Rio TInto (NYSE:<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a>), Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>), Anglo American (<a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>) and Antofagasta (<a href='https://seekingalpha.com/symbol/ANFGF' title='Antofagasta plc'>OTC:ANFGF</a>) are <a href=\"http://www.cityam.com/258941/surge-copper-prices-boosting-shares-londons-ftse-100-miners\" target=\"_blank\">higher by 1.7%-2.2%</a> in London trading; Vale (NYSE:<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>) <font color='green'>+4.6%</font>, Cliffs Natural Resources (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a>)&nbsp;<font color='green'>+2.4%</font>, Freeport McMoRan (NYSE:<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a>) <font color='green'>+1.6%</font> in premarket U.S. trading.</li>     <li>Copper recently traded traded at $6,126/metric ton after jumping more than 4% on Friday, its biggest one-day rise in nearly four years.</li>     <li>BHP <a href=\"https://seekingalpha.com/news/3242614-bhps-escondida-copper-mine-declares-force-majeure\" target=\"_blank\">declared force majeure</a> at its Escondida mine in Chile on Friday, and the mine was <a href=\"https://www.bloomberg.com/news/articles/2017-02-13/bhp-vows-legal-action-at-top-copper-mine-after-group-enters-site\" target=\"_blank\">attacked over the weekend</a> by vandals who forced contract workers to stop work during an ongoing strike.</li>     <li>At the same time, exports at FCX's Grasberg site in Indonesia have been suspended for a month.</li><li>\"In the near term, copper prices should continue to trade on headlines  from Escondida as well as from the large Grasberg mine in Indonesia,  which is also at risk of production disruptions if an export permit is  not granted by the government in the coming weeks,\" J.P. Morgan <a href=\"https://secure.marketwatch.com/story/copper-prices-edge-to-fresh-high-on-supply-worries-2017-02-13\" target=\"_blank\">says</a>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3242807\" data-linked=\"Global miners move higher alongside copper prices\" data-tweet=\"$BHP $BHP $RIO - Global miners move higher alongside copper prices https://seekingalpha.com/news/3242807-global-miners-move-higher-alongside-copper-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3242807-global-miners-move-higher-alongside-copper-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242805\" data-ts=\"1486992217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242805-macys-on-move-after-barrons-tees-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s on the move after Barron&#39;s tees it up</a></h4><ul> <li>Shares of Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) are <font color='green'>up 1.75%</font> to $32.55 after investors take note of a positive profile of the department store operator in Barron's.</li> <li>While Barron's and others are pointing to the new strategy from Macy's management as long-term EPS growth drivers, SA contributor Simply Safe Dividends <a href=\"https://seekingalpha.com/article/4044511-macys-household-name-high-risky-dividend\" target=\"_blank\">reminds</a> that the 4.72% yield on Macy's is also attractive.</li> <li>Macy's hasn't traded over $34 since January 4.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3242703-macys-50-percent-upside-sale-barrons\" target=\"_blank\">Macy's could have 50% upside in a sale - Barron's</a> (Feb. 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242805\" data-linked=\"Macy&#39;s on the move after Barron&#39;s tees it up\" data-tweet=\"$M - Macy&#39;s on the move after Barron&#39;s tees it up https://seekingalpha.com/news/3242805-macys-on-move-after-barrons-tees-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3242805-macys-on-move-after-barrons-tees-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242804\" data-ts=\"1486992087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242804-allergan-takes-out-zeltiq-for-2_47b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan takes out ZELTIQ for $2.47B</a></h4><ul><li>Allergan (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) <a href=\"https://seekingalpha.com/pr/16740119-allergan-acquire-zeltiq-best-class-company-fast-growing-body-contouring-segment-2_47-billion\" target=\"_blank\">acquires </a>body contouring outfit ZELTIQ Aesthetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ZLTQ' title='ZELTIQ Aesthetics, Inc.'>ZLTQ</a>) for $2.47B ($56.50/share). ZELTIQ's flagship product is the CoolSculpting System used to reduce unwanted fat. The transaction, which will be immediately accretive, should close in H2.</li><li>Allergan will host a conference call at 9:00 am ET to discuss the deal.</li><li>ZLTQ closed Friday at $49.40.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242804\" data-linked=\"Allergan takes out ZELTIQ for $2.47B\" data-tweet=\"$AGN $AGN $ZLTQ - Allergan takes out ZELTIQ for $2.47B https://seekingalpha.com/news/3242804-allergan-takes-out-zeltiq-for-2_47b?source=tweet\" data-url=\"https://seekingalpha.com/news/3242804-allergan-takes-out-zeltiq-for-2_47b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242802\" data-ts=\"1486991833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242802-applied-materialsplus-1_5-outperformance-reiterated-target-increased-to-40-cowen-and-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Materials +1.5%; outperformance reiterated, target increased to $40 at Cowen and Company</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Applied+Materials+%28AMAT%29+PT+Raised+to+%2440+at+Cowen%3B+Sees+Strong+Q1+Results/12531534.html\" target=\"_blank\">Analyst Timothy Arcuri</a>: \"See strong results w/guide that seems more likely ~$0.70 as a bogey (Street $0.63). Given spending mix in '17, AMAT seems unlikely to lose share and should gain; ergo, if WFE=$36B or better (AMAT 22.9% WFE share in '16), SSG should do ~$8.5B and Street still looks too low for C2017. Increasing estimates + target to $40 with C2018 EPS now $3.20 which ought to ultimately support $40.\" Target from $33 prior.</li><li>Q1 2017 results are scheduled for release <a href=\"http://investors.appliedmaterials.com/phoenix.zhtml?c=112059&amp;p=irol-EventDetails&amp;EventId=5247937\" target=\"_blank\">Wednesday, February 15</a>.</li><li>Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) $35.85 pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242802\" data-linked=\"Applied Materials +1.5%; outperformance reiterated, target increased to $40 at Cowen and Company\" data-tweet=\"$AMAT - Applied Materials +1.5%; outperformance reiterated, target increased to $40 at Cowen and Company https://seekingalpha.com/news/3242802-applied-materialsplus-1_5-outperformance-reiterated-target-increased-to-40-cowen-and-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3242802-applied-materialsplus-1_5-outperformance-reiterated-target-increased-to-40-cowen-and-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242801\" data-ts=\"1486991733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242801-goldman-sachs-sees-hasbro-rally-extending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs sees Hasbro rally extending</a></h4><ul> <li>Shares of Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>) are on watch after Goldman Sachs initiates coverage with a Buy rating.</li> <li>The investment firm sets a price target of $110. Hasbro hit a new all-time high of $98.26 last week after Q4 results shined.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3240759-hasbro-runs-time-high-earnings\" target=\"_blank\">Hasbro runs to all-time high after earnings</a> (Feb. 6)</li> <li>HAS <font color='green'>+0.99%</font> premarket to $98.60.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242801\" data-linked=\"Goldman Sachs sees Hasbro rally extending\" data-tweet=\"$HAS - Goldman Sachs sees Hasbro rally extending https://seekingalpha.com/news/3242801-goldman-sachs-sees-hasbro-rally-extending?source=tweet\" data-url=\"https://seekingalpha.com/news/3242801-goldman-sachs-sees-hasbro-rally-extending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242797\" data-ts=\"1486991252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXON\" target=\"_blank\">AXON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242797-axovants-nelotanserin-shows-treatment-benefit-in-mid-stage-dementia-study-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant&#39;s nelotanserin shows treatment benefit in mid-stage dementia study; shares up 5% premarket</a></h4><ul><li>Thinly traded Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) perks up&nbsp;<font color='green'>5%&nbsp;</font>premarket, albeit on only 800 shares, in response to its <a href=\"https://seekingalpha.com/pr/16739979-axovant-sciences-announces-preliminary-results-interim-analysis-phase-2-study-testing\" target=\"_blank\">announcement </a>of positive interim results (n=11) from a Phase 2 clinical trial assessing nelotanserin in patients with Lewy body dementia &#40;LBD&#41;.</li><li>The primary endpoint of the trial, which also includes patients with Parkinson's disease dementia &#40;PDD&#41;, is the change from baseline in a rating scale called UPDRS Parts II &amp; III. The preliminary results were statistically valid compared to placebo (p&lt;0.05).</li><li>The data fell short of statistical significance on an internally developed endpoint that measured episodes of hallucinations using a patient diary.</li><li>The company intends to expand enrollment to confirm the results. The full study should be completed by mid-year. Complete results will be presented at a future scientific meeting in 2017. A Phase 3 study will commence in H2.</li><li><a href=\"http://axovant.com/pipeline/nelotanserin/\" target=\"_blank\">Nelotanserin </a>is a highly selective inverse agonist of the 5HT2A receptor, a serotonin receptor associated with motor symptoms and neuropsychiatric disturbances including visual hallucinations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242797\" data-linked=\"Axovant&#39;s nelotanserin shows treatment benefit in mid-stage dementia study; shares up 5% premarket\" data-tweet=\"$AXON $AXON-OLD - Axovant&#39;s nelotanserin shows treatment benefit in mid-stage dementia study; shares up 5% premarket https://seekingalpha.com/news/3242797-axovants-nelotanserin-shows-treatment-benefit-in-mid-stage-dementia-study-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3242797-axovants-nelotanserin-shows-treatment-benefit-in-mid-stage-dementia-study-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242787\" data-ts=\"1486990729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242787-boeingminus-1_4-on-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing -1.4% on downgrade</a></h4><ul><li>Details aren't yet available, but Buckingham's Richard Safran has downgraded Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) to Underperform from Neutral.</li><li>Nearly a year ago to the day, Safran upgrading Boeing to Neutral from Underperform, and the stock's&nbsp;<font color='green'>higher by more than 40%</font>&nbsp;since.</li><li>Shares&nbsp;<font color='red'>-1.4%</font>&nbsp;in modest premarket action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242787\" data-linked=\"Boeing -1.4% on downgrade\" data-tweet=\"$BA - Boeing -1.4% on downgrade https://seekingalpha.com/news/3242787-boeingminus-1_4-on-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3242787-boeingminus-1_4-on-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}